^
8ms
Clinical • IO biomarker • Metastases
|
PD-L1 (Programmed death ligand 1)
|
PD-L1 expression
|
Keytruda (pembrolizumab) • Sutent (sunitinib) • Lenvima (lenvatinib)
8ms
Clinical
|
FGFR (Fibroblast Growth Factor Receptor)
|
FGFR mutation
|
Balversa (erdafitinib) • Padcev (enfortumab vedotin-ejfv)